Você está na página 1de 75

# CHAPTER 2 Mathematics Review

## Author: Michael Makoid, Phillip Vuchetich and John Cobby

Reviewer: Phillip Vuchetich

## BASIC MATHEMATICAL SKILLS OBJECTIVES

1. Given a data set containing a pair of variables, the student will properly construct
(III) various graphs of the data.
2. Given various graphical representations of data, the student will calculate (III) the
slope and intercept by hand as well as using linear regression.
3. The student shall be able to interpret (V) the meaning of the slope and intercept
for the various types of data sets.
4. The student shall demonstrate (III) the proper procedures of mathematical and
algebraic manipulations.
5. The student shall demonstrate (III) the proper calculus procedures of integration
and differentiation.
6. The student shall demonstrate (III) the proper use of computers in graphical simu-
lations and problem solving.
7. Given information regarding the drug and the pharmacokinetic assumptions for
the model, the student will construct (III) models and develop (V) equations of the
ADME processes using LaPlace Transforms.
8. The student will interpret (IV) a given model mathematically.
9. The student will predict (IV) changes in the final result based on changes in vari-
ables throughout the model.
10. The student will correlate (V) the graphs of the data with the equations and mod-
els so generated.

## Basic Pharmacokinetics REV. 00.1.6 2-1

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.1 Concepts of Mathematics

Pharmacokinetcs is a challenging field involving the application of mathematical
concepts to real situations involving the absorbtion, distribution, metabolism and
excretion of drugs in the body. In order to be successful with pharmacokinetics, a
certain amount of mathematical knowledge is essential.
This is just a review. This chapter is meant to review the concepts in mathematics essential for under-
Look it over. You should standing kinetics. These concepts are generally taught in other mathematical
be able to do all of these courses from algebra through calculus. For this reason, this chapter is presented as
manipulations.
a review rather than new material. For a more thorough discussion of any particu-
lar concept, refer to a college algebra or calculus text.

## Included in this section are discussions of algebraic concepts, integration/differen-

tiation, graphical analysis, linear regression, non-linear regression and the LaPlace
transform. Pk Solutions is the computer program used in this course.
Something new - A critical concept introduced in this chapter is the LaPlace transform. The LaPlace
LaPlace transforms. transform is used to quickly solve (integrate) ordinary, linear differential equa-
Useful tool.
tions. The Scientist by Micromath Scientific Software, Inc.1 is available for work-
ing with the LaPlace transform for problems throughout the book.

1. MicroMath Scientific Software, Inc., P.O. Box 21550, Salt Lake City, UT 84121-0550,

## Basic Pharmacokinetics REV. 00.1.6 2-2

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.2.1 ZERO AND INFINITY

Any number multiplied by zero equals zero. Any number multiplied by infinity
( ∞ ) equals infinity. Any number divided by zero is mathematically undefined.
Any number divided by infinity is mathematically undefined.

## 2.2.2 EXPRESSING LARGE AND SMALL NUMBERS

Large or small numbers can be expressed in a more compact way using indices.
5
How Does Scientific Examples: 316000 becomes 3.16 × 10
Notation Work?
–3
0.00708 becomes 7.08 ×10

n
A × 10

## Where A is a value between 1 and 10, and n is a positive or negative integer

The value of the integer n is the number of places that the decimal point must be
moved to place it immediately to the right of the first non-zero digit. If the decimal
point has to be moved to its left then n is a positive integer; if to its right, n is a
negative integer.

## Because this notation (sometimes referred to as “Scientific Notation”) uses indi-

ces, mathematical operations performed on numbers expressed in this way are sub-
ject to all the rules of indices; for these rules see Section 2.2.4.

A shorthand notation (AEn) may be used, especially in scientific papers. This may
n
be interpreted as A × 10 , as in the following example:

4
2.28E4 = 2.28 ×10 = 22800

## Basic Pharmacokinetics REV. 00.1.6 2-3

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## A significant figure is any digit used to represent a magnitude or quantity in the

place in which it stands. The digit may be zero (0) or any digit between 1 and 9.
For example:

## TABLE 2-1 Significant Figures

Number of
Significant Significant
Value Figures Figures
(a) 572 2,5,7 3
(b) 37.10 0,1,3,7 4
(c) 10.65 x 104 0,1,6,5 4
(d) 0.693 3,6,9 3
(e) 0.0025 2,5 2

How do I determine the Examples (c) to (e) illustrate the exceptions to the above general rule. The value 10
number of significant raised to any power, as in example (c), does not contain any significant figures;
figures? hence in the example the four significant figures arise only from the 10.65. If one
or more zeros immediately follow a decimal point, as in example (e), these zeros
simply serve to locate the decimal point and are therefore not significant figures.
The use of a single zero preceding the decimal point, as in examples (d) and (e), is
a commendable practice which also serves to locate the decimal point; this zero is
therefore not a significant figure.
What do significant fig- Significant figures are used to indicate the precision of a value. For instance, a
ures mean? value recorded to three significant figures (e.g., 0.0602) implies that one can reli-
ably predict the value to 1 part in 999. This means that values of 0.0601, 0.0602,
and 0.0603 are measurably different. If these three values cannot be distinguished,
they should all be recorded to only two significant figures (0.060), a precision of 1
part in 99.

After performing calculations, always “round off” your result to the number of sig-
nificant figures that fairly represent its precision. Stating the result to more signifi-
cant figures than you can justify is misleading, at the very least!

## Basic Pharmacokinetics REV. 00.1.6 2-4

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.2.4 RULES OF INDICES

n
What is an index? An index is the power to which a number is raised. Example: A where A is a
number, which may be positive or negative, and n is the index, which may be pos-
itive or negative. Sometimes n is referred to as the exponent, giving rise to the
general term, “Rules of Exponents”. There are three general rules which apply
when indices are used.

(a) Multiplication

A n n+m
=  --- × B
n m n+m n m
A ×A = A A ×B
B

(b) Division

n n n n–m
A-
------ = A
n–m A-
------ = A--- × B
m m  B
A B

n m nm
(A ) = A

## (i) Negative Index

–n 1 –n
A = -----n- As n tends to infinity ( n → ∞ ) then A → 0 .
A

1
---
n n
A = A

0
A = 1

## Basic Pharmacokinetics REV. 00.1.6 2-5

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

2.2.5 LOGARITHMS
What is a logarithm? Some bodily processes, such as the glomerular filtration of drugs by the kidney,
are logarithmic in nature. Logarithms are simply a way of succinctly expressing a
number in scientific notation.

## In general terms, if a number (A) is given by

n
A = 10 then log ( A ) = n

where ‘log’ signifies a logarithm to the base 10, and n is the value of the logarithm
of (A).

5
Example: 713000 becomes 7.13 × 10 ,

## 0.85 0.85 5 ( 5 + 0.85 ) 5.85

and 7.13 = 10 , thus 713000 becomes 10 × 10 = 10 = 10

## Logarithms to the base 10 are known as Common Logarithms. The transformation

of a number (A) to its logarithm (n) is usually made from tables, or on a scientific
calculator; the reverse transformation of a logarithm to a number is made using
anti-logarithmic tables, or on a calculator.
What is the characteris- The number before the decimal point is called the characteristic and tells the place-
tic? the mantissa? ment of the decimal point (to the right if positive and to the left if negative). The
number after the decimal is the mantissa and is the logarithm of the string of num-
bers discounting the decimal place.

## 2.2.6 NATURAL LOGARITHMS

What is a natural loga- Instead of using 10 as a basis for logarithms, a natural base (e) is used. This natural
rithm? base is a fundamental property of any process, such as the glomerular filtration of a
drug, which proceeds at a rate controlled by the quantity of material yet to undergo
the process, such as drug in the blood. To eight significant figures, the value of the
transcendental function, e, is

1 Where x is an inte-
e = 2.7182818 ... Strictly speaking, e = 1 + ∑ ---x!-
x=1
ger ranging from 1 to infinity ( ∞ ) ,

## Basic Pharmacokinetics REV. 00.1.6 2-6

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

x=1

## ! is the factorial (e.g., 6! = 6x5x4x3x2x1= 720)

n
In general terms, if a number (A) is given by A = e , then by definition,
ln ( A ) = n

Where, ‘ln’ signifies the natural logarithm to the base e , and n is the value of the
natural logarithm of A .

## Natural logarithms are sometimes known as Hyperbolic or Naperian Logarithms;

again tables are available and scientific calculators can do this automatically. The
anti-logarithm of a natural logarithm may be found from exponential tables, which
n
give the value of e for various values of n.
How are natural loga- Common and natural logarithms are related as follows:
rithms ln x and common
logarithms log x related? ln ( A ) = 2.303 × log ( A ) , and

log ( A ) = 0.4343 × ln ( A )

Because logarithms are, in reality, indices of either 10 or e , their use and manipu-
lation follow the rules of indices (See Section 2.2.4).

(a) Multiplication:

n m n m n+m
To multiply N × M , where N = e and M = e ; NM = e × e = e .

By definition, ln ( NM ) = n + m ; but

n = ln ( N ) and m = ln ( M ) , hence ln ( NM ) = ln ( N ) + ln ( M )

Thus, to multiply two numbers (N and M) we take the natural logarithms of each,
add them together, and then take the anti-logarithm (the exponent, in this case) of
the sum.

## Basic Pharmacokinetics REV. 00.1.6 2-7

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

(b) Division

ln  ----- = ln ( N ) – ln ( M )
N
 M

## (c) Number Raised to a Power

m
ln ( N ) = m × ln ( N )

## (i) Number Raised to a Negative Power

) = – m × ln ( N ) = m × ln  ----
–m 1
ln ( N
N

–m
As m tends to infinity ( m → ∞ ) , then ln ( N ) → –∞

## (ii) Number Raised to a Fractional Power

1
 ---
m
-
1
ln ( m N ) = ln  N  = ---- × ln ( N )
  m

## (iii) Logarithm of Unity

ln ( 1 ) = log ( 1 ) = 0

## Basic Pharmacokinetics REV. 00.1.6 2-8

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## The number 0.00713 may be expressed as:

–3
7.13 ×10 , or

0.85 –3
10 × 10 , or

– 2.15
10 .

Hence, log ( 0.00713 ) = – 2.15 , which is the result generated by most calculators.

## However, another representation of a negative logarithm (generally used by refer-

encing a log table):

## log (0.00713) = 3.85

The 3 prior to the decimal point is known as the characteristic of the logarithm; it
can be negative (as in this case) or positive, but is never found in logarithmic
tables. The .85 following the decimal point is known as the mantissa of the loga-
rithm; it is always positive, and is found in logarithmic tables.

In fact 3 is a symbolic way of writing minus 3 (-3) for the characteristic. In every
case the algebraic sum of the characteristic and the mantissa gives the correct
value for the logarithm.

## Result is -2.15, which is the value of log ( 0.00713 )

The reason for this symbolism is that only positive mantissa can be read from anti-
logarithmic tables, and hence a positive mantissa must be the end result of any log-
arithmic manipulations. Note that while there are negative logarithms (when N <
1), they do not indicate that number itself is negative; the sign of a number (e.g., -
N) is determined only by inspection following the taking of anti-logarithms.

## Basic Pharmacokinetics REV. 00.1.6 2-9

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Though the preferred method to using logarithms is with a calculator or computer,

the understanding of how the number is being manipulated may be important in
understanding the use of logarithms. (See the end of this chapter for Logarithm
tables).

## (a) Find the log of (62.54):

1
1. convert 62.54 to scientific notation ---> 62.54 = 6.254 ×10 ;
2. Look up the mantissa for 6254 in a table of logarithms: it is 7962.
1 0.7962 1 1.7962
3. Hence, 6.254 ×10 = 10 × 10 = 10 and log ( 62.54 ) = 1.7962

## (b) Find the log of (0.00329)

–3
1. 0.00329 = 3.29 ×10
2. The mantissa for 329 is 5172
3. Hence, log(0.00329) = 3.5172.

Note that in both examples the value of the characteristic is the integer power to
which 10 is raised when the number is written in scientific notation.
How do I multiply using (c) Multiply 62.54 by 0.00329
logarithms?
log (62.54) = 1.7972

## log (62.54 + log (0.00329) = 1.7962+3.5172 = 1.7962-3+ 0.5172=-0.6866

0.6866=1.3134

(d) We wish to find anti-log (1.3134) Look up the anti-log for the 0.3134 (man-
tissa) in a table: it is 2058.

–1
Antilog (1.3134) = 2.058 ×10

## Hence, antilog (1.3134) = 0.2058

How do I divide using log (62.54) - log (0.00329) = 1.796 - 3.5172=1.796 +3 - 0.5172=4.2788
logarithms?
antilog 4.2788 = 19002

## Basic Pharmacokinetics REV. 00.1.6 2-10

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

2.2.9 DIMENSIONS
What is a unit? There are three fundamental dimensions which are used in various combinations to
express the properties of matter. Each of these dimensions has been assigned a def-
inite basic unit, which acts as a reference standard.

## TABLE 2-2 Dimensions

Dimensional
Dimension Symbol Unit Unit Symbol
Length L meter m
Mass M gram g
Time T second sec

How are units made big- In the metric system, which emerged from the French Revolution around 1799,
ger and smaller? there are various prefixes which precede the basic units and any derived units. The
prefixes indicate the factor by which the unit is multiplied. When the index of the
factor is positive the prefixes are Greek and have hard, consonant sounds. In con-
trast, when the index is negative, the prefixes are Latin and have soft, liquid
sounds. (see Table 2-3).
How big is big? Examples: An average adult male patient is assumed to have a mass of 70 kilo-
grams (70 kg). An average adult male patient is assumed to have a height of 180
centimeters (180 cm). A newly minted nickel has a mass of 5.000 g. Doses of
drugs are in the mg (10-3 g) range (occasionally g) never Kg (103 g) or larger. Stu-
dents have told me that the dose that they have calculated for their patient is 108 g
(converting to common system - ~ 100 tons). I doubt it. Get familiar with this sys-
tem. Note that the plural of Kg or cm is Kg or cm; do not add an “s”. In pharmacy
there are two derived units which are commonly used, even though they are
related to basic units. The Liter (L) is the volume measurement and is a cube 10
cm on a side (1L = (10cm)3 = 1000 cm3 ) while the concentration measurement
and has the units of Mass per Volume.
Why should I use units? Whenever the magnitude of a measured property is stated, it is imperative to state
the units of the measurement. Numbers are useless by themselves.

Example: The procainamide concentration range is 4-8 µ g/ml; stating the range
without units may lead to a potentially lethal error in which procainamide is
administered in a sufficient dose to attain a range of 4-8 mg/ml, which is 1000
times too large and would give rise to cardiac arrest.

## Basic Pharmacokinetics REV. 00.1.6 2-11

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Name Symbol Multiplication Factor Name Symbol Multiplication Factor

exa- E 18 deci- d –1
10 10
peta- P 15 centi- c –2
10 10
tera- T 12 milli- m –3
10 10
giga- G
10
9 micro- µ 10
–6

mega- M 6 nano- n –9
10 10
kilo- k 3 pico- p –12
10 10
hecto- h 2 femto- f –15
10 10
deca- da 1 atto- a –18
10 10

TABLE 2-4

Dimensional Unit
Dimension Symbol Unit Symbol
Volume V liter l
Concentration C grams/liter g/l

## Basic Pharmacokinetics REV. 00.1.6 2-12

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.2.10 DIMENSIONAL ANALYSIS

How are units useful? It is a general rule that the net dimensions (and units) on the two sides of any equa-
tion should be equal. If this is not so, the equation is necessarily meaningless.

Consider the following equation which defines the average concentration of a drug
FD
in blood after many repeated doses, ( C b )∞ = -----------
VKτ

Where:
• F is the fraction of the administered dose ultimately absorbed (Dimensions: none),
• D is the mass of the repeated dose (Dimension: M),
• V is the apparent volume of distribution of the drug (Dimension: V = L )
–1
• K is the apparent first-order rate constant for drug elimination (Dimension: T ),

## • and τ is the dosing interval (Dimension: T )

Writing the dimensions relating to the properties of the right-hand side of the equa-
tion gives:

M - M
----------------------- = -----
–1 V
V⋅T ⋅T

M
Thus ( C b )∞ has the dimensions of ----- , which are correctly those of concentration.
V

## Sometimes dimensional analysis can assist an investigator in proposing equations

which relate several properties one with the other. If the units cancel, and you end
up with the correct unit of measure, you probably did it right. If you obtain units
that do not make sense, it’s guaranteed sure that you did it wrong.

## Basic Pharmacokinetics REV. 00.1.6 2-13

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

2.3 Calculus
What is Calculus? Calculus concerns either the rate of change of one property with another (differen-
tial calculus), such as the rate of change of drug concentrations in the blood with
time since administration, or the summation of infinitesimally small changes (inte-
gral calculus), such as the summation of changing drug concentrations to yield an
assessment of bioavailability. In this discussion a few general concepts will be pro-
vided, and it is suggested an understanding of graphical methods should precede
this discussion.

## 2.3.2 NON-LINEAR GRAPHS

3
Consider the following relationship: y = x

## TABLE 2-5 x, y sample data

x 0 1 2 3 4
y 0 1 8 27 64

As can be seen from the graph (Figure 2-1), a non-linear plot is produced, as
expected.

## FIGURE 2-1. y=x3

70
60
50
40
30
20
10
0
1 2 3 4

(Question: How could the above data be modified to give a linear graph?)

## Basic Pharmacokinetics REV. 00.1.6 2-14

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## As with a linear graph,

y2 – y1 ∆y
---------------- = ------
x2 – x1 ∆x

## Where ∆y is the incremental change in y and ∆x is the incremental change in x

But, as can be seen (Figure 1), the slope is not constant over the range of the graph;
it increases as x increases. The slope is a measure of the change in y for a given
change in x. It may then be stated that:

“the rate of change of y with respect to x varies with the value of x.”

## 2.3.4 VALUE OF THE SLOPE

3
We need to find the value of the slope of the line y = x when x = 2 (See Figure
1). Hence, we may choose incremental changes in x which are located around
x ≈ 2.

## FIGURE 2-2. ∆y / ∆x when x ≈ 2

∆y
------
x1 x2 ∆x y1 y2 ∆y ∆x
0 4 4 0 64 64 16.000
1 3 2 1 27 26 13.000
1.5 2.5 1.0 3.375 15.625 12.250 12.250
1.8 2.2 0.4 5.832 10.648 4.816 12.040
1.9 2.1 0.2 6.859 9.261 2.042 12.010
1.95 2.05 0.1 7.415 8.615 1.200 12.003

As may be seen, the value of the slope ∆-----y- tends towards a value of 12.000 as the
 ∆x 
magnitude of the incremental change in x becomes smaller around the chosen
value of 2.0. Were the chosen incremental changes in x infinitesimally small, the
true value of the slope (i.e., 12.000) would have appeared in the final column of
the above table.

## Basic Pharmacokinetics REV. 00.1.6 2-15

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Calculus deals with infinitesimally small changes. When the value of ∆x is infini-
tesimally small it is written dx and is known as the derivative of x. Hence,

dy
------ = f ( x )
dx

Where dy/dx is the derivative of y with respect to x and f ( x ) indicates some func-
tion of x.

## Differentiation is the process whereby the derivative of y with respect to x is

found. Thus the value of dy/dx, in this case, is calculated.
(a) Considering again the original expression:

3
y = x

## (b) Let the value of y increase to y + dy because x increases to x + dx .

Hence,
3
y + dy = ( x + dx ) (EQ 2-13)

Multiplying out:
3 2 2 3
y + dy = x + 3x ( dx ) + 3x ( dx ) + ( dx ) (EQ 2-14)

(c) The change in y is obtained by subtraction of the original expression from the
last expression. (i.e., Eq. 2 - Eq. 1)
2 2 3
dy = 3x ( dx ) + 3x ( dx ) + ( dx ) (EQ 2-15)

## Dividing throughout to obtain the derivative,

dy
------ = 3x 2 + 3x ( dx ) + ( dx )2
dx

## When dx is infinitesimally small, its magnitude tends to zero ( dx → 0 ) . The limit-

ing value of this tendency must be dx = 0 . At this limit,

## Basic Pharmacokinetics REV. 00.1.6 2-16

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

dy
------ = 3x 2 (EQ 2-16)
dx

2
Hence the derivative of y with respect to x at any value of x is given by 3x .

(d) In section 2.3.4 we saw how the true value of the slope (i.e., dy/dx) would be
12.0 when x = 2 . This is confirmed by substituting in Equation 1-16.

dy
------ = 3x 2 = 3 ( 2 2 ) = 12
dx

## 2.3.6 RULE OF DIFFERENTIATION

Although the rate of change of one value with respect to another may be calculated
as above, there is a general rule for obtaining a derivative.

## Let x be the independent variable value, y be the dependent variable value, A be a

constant, and n be an exponential power.

## The general rule is:

n
If y = Ax

then

dy
------ = nAx n – 1
dx

The Rules of Indices may need to be used to obtain expressions in the form
n
y = Ax

(e.g., if y = 5 x)

0
(a) If y = Ax ,

## Basic Pharmacokinetics REV. 00.1.6 2-17

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

dy
Hence, ------ = 0
dx

## (b) Accept that if y = ln ( x )

dy 1
then ------ = --- .
dx x

## This derivative is important when considering apparent first-order processes, of

which many bodily processes (e.g., excretion of drugs) are examples.

Ax
(c) Accept that if y = Be where B and A are constants, and e is the natural
dy Ax
base then ------ = ABe
dx

This derivative will be useful in pharmacokinetics for finding the maximum and
minimum concentrations of drug in the blood following oral dosing.

## Consider the following two expressions:

n
(a) If y = Ax , then

dy n–1
------ = nAx
dx

n
(b) If y = Ax + A ,

dy n–1 n–1
then ------ = nAx + 0 = nAx
dx

Both of the original expressions, although different, have the same derivative. This
fact is recognized later when dealing with integral calculus.

## Basic Pharmacokinetics REV. 00.1.6 2-18

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Generally integral calculus is the reverse of differential calculus. As such it is used

to sum all the infinitesimally small units (dy) into the whole value (y).

Thus,

## The derivative expression may be written:

dy
------ = Ax n , or
dx

n
dy = Ax ⋅ dx

To integrate,

∫ dy ∫ Ax dx = A ∫ x dx
n n
y = =

## A general rule states:

n+1
Ax
A ∫ x dx = ---------------- + A
n
n+1

Where A is the constant of integration However, there is one exception - the rule
is not applicable if n = – 1

dy 2
Example: If ------ = 3x (See section 2.3.5),
dx

2+1
3x
then y = --------------- + A , and
2+1

3
y = x +A

## Basic Pharmacokinetics REV. 00.1.6 2-19

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.3.11 THE CONSTANT OF INTEGRATION

There has to be a constant in the final integrated expression because of the seeming
3 3
anomaly referred to in section 2.3.8. As mentioned, both y = x and y = x + A
dy 2
will give, on differentiation, ------ = 3x .
dx

So whether or not a constant is present and, if so, what is its value, can only be
decided by other knowledge of the expression. Normally this other knowledge
takes the form of knowing the value of y when x = 0 .

In the case of our graphical example we know that when x = 0 , then y = 0 . The
integrated expression for this particular case is:

3
y = x + A , therefore

3
0 = 0 + A , thus A = 0

In some examples, such as first-order reaction rate kinetics, the value of A is not
zero.

## 2.3.12 THE EXCEPTION TO THE RULE

It occurs when n = – 1

1
y = A ∫ x dx = A ∫ --- dx
–1
x

Upon integration, y = A ⋅ ln ( x ) + A

dy
------ = Be Ax
dx

## Basic Pharmacokinetics REV. 00.1.6 2-20

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

then,

Ax
Be
y = ----------- + A
A

This integral will be useful for equations which define the bioavailability of a drug
product.

## 2.3.14 EXAMPLE CALCULATIONS

(a) Consider,

2
c = 3t ( t – 2 ) + 5

3 2
c = 3t – 6t + 5

## The rate of dissolution at time t is

dc
------ = 9t 2 – 12t
dt

## So at any time, the rate may be calculated.

dc 2
(b) Consider, ------ = 3t ( t – 4 ) = 9t – 12t
dt

Then rearranging,

2
dc = 9t ⋅ dt – 12 ⋅ dt

## The integral of c is:

∫ dc
3 2
c = = 3t + A – 6t + B

## Basic Pharmacokinetics REV. 00.1.6 2-21

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

3 2
c = 3t = 6t + D

where D = A + B

2 2
c = 3t + 6t + 5

## (c) Following administration of a drug as an intravenous injection,

– dC p
------------- = KC p
dt

## K is the apparent first-order rate constant of elimination.

Rearranging,

1
– K ⋅ dt = ------ ⋅ dC p
Cp

1
– Kt = – K ∫ dt = ∫ -----
- ⋅ dC p
Cp

## This integral is the exception to the rule (see section 2.3.12).

– Kt = ln ( C p ) + A

## Basic Pharmacokinetics REV. 00.1.6 2-22

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Substituting, 0 = ln ( C p )0 + A

Or,

A = – ln ( C p )0

Hence

– Kt = ln ( C p ) – ln ( C p ) 0

or,

ln ( C p ) = ln ( C p ) 0 – Kt

or,

– Kt
Cp = ( C p )0 ⋅ e

## Basic Pharmacokinetics REV. 00.1.6 2-23

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

2.4 Graphs
Why do we graph? We would like to organize the chaotic world around us so that we can predict (see
into the future) and retrodict (see into the past) what will happen or has happened.
Our recorded observations are collectively known as data. We make a theory
about what we think is happening and that theory is expressed in an equation. That
determines our paradigm of how we see the world. This paradigm is expressed as
a graph. The language of science is mathematics and graphs are its pictures.

TABLE 2-6

English Science
Observations Data
Theory Equations
Paradigms (pictures) Graphs

What is a graph? A graph is simply a visual representation showing how one variable changes with
alteration of another variable. The simplest way to represent this relationship
between variables is to draw a picture. This pictorializing also is the simplest way
for the human mind to correlate, remember, interpolate and extrapolate perfect
data. An additional advantage is it enables the experimenter to average out small
deviations in experimental results (non-perfect, real data) from perfect data. For
example:

Perfect Real
-3 -5 -4.6
-2 -3 -3.4
-1 -1 -0.6
0 +1 +0.8
+1 +3 +3.4
+2 +5 +4.4

## Basic Pharmacokinetics REV. 00.1.6 2-24

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## FIGURE 2-3. Plot of Perfect vs. Real data

-2

-4

-6
-3 -2 -1 0 1 2

Simply looking at the columns x and y (real) it might be difficult to see the rela-
tionship between the two variables. But looking at the graph, the relationship
becomes apparent. Thus, the graph is a great aid to clear thinking. For every graph
relating variables, there is an equation and, conversely for every equation there is a
graph. The plotting of graphs is comparatively simple. The reverse process of find-
ing an equation to fit a graph drawn from experimental data is more difficult,
except in the case of straight lines.

## 2.4.1 GRAPHICAL CONVENTIONS

How are graphs made? Certain conventions have been adopted to make the process of rendering a data set
to a graphical representation extremely simple.

The ‘y’ variable, known as the dependent variable, is depicted on the vertical axis
(ordinate); and the ‘x’ variable, known as the independent variable, is depicted on
the horizontal axis (abscissa). It is said that ‘y’ varies with respect to ‘x’ and not
‘x’ varies with ‘y’.

A decision as to which of the two related variables is dependent can only be made
be considering the nature of the experiment. To illustrate, the plasma concentration
of a drug given by IV bolus depends on time. Time does not depend on the plasma
concentration. Consequently, plasma concentration would be depicted on the ‘y’
axis and time on the ‘x’ axis.

## Basic Pharmacokinetics REV. 00.1.6 2-25

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Any point in the defined space of the graph has a unique set of coordinates: 1) the
‘x’ value which is the distance along the ‘x’ axis out from the ‘y’ axis and always
comes first; and 2) the ‘y’ value which is the distance, along the ‘y’ axis up or
down from the ‘x’ axis, and always comes second. Several points are shown in
Figure 2. For example, (0,1) is on the line and (1,0) is not.

The intersection of x and y axis is the origin with the coordinates of (0,0). In two
dimensional spaces, the graph is divided into 4 quadrants from (0,0), numbered
with Roman numerals from I through IV. It should be readily apparent that the
coordinates for all points within a particular quadrant are of the same sign type i.e.,

## TABLE 2-8 Quadrants on a cartesian graph

Quadrant II (-x, +y) Quadrant I (+x, +y)
Quadrant III (-x, -y) Quadrant IV (+x, -y)

## A line (or curve) on a graph is made up of an infinite number of points, each of

which has coordinates that satisfy a given equation. For example, each point on the
line in Figure 2 is such at its coordinates fit the equation y = 2x + 1 . That is for
any value of x (the independent variable), multiplying the x value by 2 and adding
1 results in the y value (the dependent variable).

## 2.4.2 STRAIGHT LINE GRAPHS

What is a straight line? A graph is a straight line (linear) only if the equation from which it is derived has
the form

y = mx + b

Where:
• y = dependent variable
• x = independent variable
• m = slope of the straight line = ∆
-----y-
∆x
• b = the y intercept (when x = 0)
• or if the equation can be “linearized”, e.g.,

mx′
y′ = b′e is not linear. However. ln y′ = ln b′ + mx′

## Basic Pharmacokinetics REV. 00.1.6 2-26

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## and consequently a plot of ln y′ (the dependent variable) versus x′ (the indepen-

dent variable) will yield a straight line with a slope of m and an intercept of ln b′ .

– Kt
C p = C p0 e

## ln C p = ln C p0 – Kt , which is in the form

y = b + mx

The graphs that yield a straight line are the ones with the ordinate being ln C p0 ,
and the abscissa being t .

## Any other combination of functions of C p and t will be non-linear, e.g.,

• C p versus t

• C p versus ln t

• ln C p versus ln t

The appropriate use of a natural logarithm in this case serves to produce linearity.
However, the use of logarithms does not automatically straighten a curved line in
all examples. Some relationships between two variables can never be resolved into
( n – m) (n – m + 1) x
a single straight line, e.g., y = k 0 + k 1 x + k2 x + … + ( k n )x

where n ≥ 2 ;n = m + 1 or

K a FD Kt –K t
C p = ------------------------- ⋅ ( e – e a )
V ( Ka – K )

(It is possible to resolve this equation into the summation of two linear graphs
which will be shown subsequently.)

## Basic Pharmacokinetics REV. 00.1.6 2-27

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.4.3 THE SLOPE OF A LINEAR GRAPH (M)

What is the slope of a From the equation a prediction may be made as to whether the slope is positive or
straight line? negative. In the previous example, the slope is negative, i.e: m = – K

## TABLE 2-9 Sample data of caffeine elimination

µg
C p  --------
t (min)  mL ln C p

12 3.75 1.322
40 2.80 1.030
65 2.12 0.751
90 1.55 0.438
125 1.23 0.207
173 0.72 -0.329

The differences in both the y-values and the x-values may be measured graphically
to obtain the value of the slope, m. Then knowing the value of m, the value of K
may be found.

## FIGURE 2-4. Plasma Concentration ( C p ) of caffeine over time

101
g/mL)
u
Caffeine Concentration (

100

10-1
0 50 100 150 200

Time (min)

## Basic Pharmacokinetics REV. 00.1.6 2-28

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.4.4 LINEAR REGRESSION: OBTAINING THE SLOPE OF THE LINE

The equation for a straight line is:

y = m⋅x+b
• y is the dependent variable
• x is the independent variable
• m is the slope of the line
• b is the intercept of the line

The equation for the slope of the line using linear regression is:

( Σ ( x ) ⋅ Σ ( y ) ) – ( n ⋅ Σ ( x ⋅ y ) -)
m = --------------------------------------------------------------------
2 2
[ Σ ( x ) ] – ( n ⋅ Σ( x ) )

## TABLE 2-10 Linear Regression for data in table 2-9

2
X Y X X⋅Y
12 1.322 144 15.864
40 1.030 1600 41.2
65 0.751 4225 48.815
90 0.438 8100 39.42
125 0.207 15625 25.875
173 -0.329 29929 -56.917
ΣX = 505 ΣY = 3.239 2
ΣX = 59623 ΣXY = 114.257

2
( ΣX ) = 255025

Σx Σy
x = ------ = 4.167 y = ------ = 0.5398
n n

Using the data from table 2-10 in the equation for the slope of the line
( 505 ⋅ 3.239 ) – ( 6 ⋅ 114.257 ) ·
m = --------------------------------------------------------------------- = – 0.01014
255025 – ( 6 ⋅ 59623 )

## and the intercept would be b = 0.5398 – ( – 0.01014 ⋅ 4.167 ) = 1.4229 .

Note that this is
ln C . In oder to find the C p0 , the anti-ln of b must be taken. i.e.
b 1.4229
Cpo = e = e = 4.15

## Basic Pharmacokinetics REV. 00.1.6 2-29

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

It is important to realize that you may not simply take any two data pairs in the
data set to get the slope. In the above data, if we simply took two successive data
pairs from the six data pairs in the set, this would result in five different slopes
( ∆x ⁄ ∆y ) ranging from -0.0066 to -0.0125 as shown in table 2-11. Clearly, this is
unacceptable. Even to guess, you must plot the data, eyeball the best fit line by
placing your clear straight edge through the points so that it is as close to the data
as possible and look to make sure that there are an equal number of points above
the line as below. Then take the data pairs from the line, not the data set.

## TABLE 2-11 Sample slope data from figure 2-4

∆y
------
Time (x) ln Conc. (y) ∆x ∆y ∆x
12 1.322 -28 0.292 -0.0104
40 1.030 -25 0.28 -0.0112
65 0.751 -25 0.312 -0.0125
90 0.438 -35 0.231 -0.0066
125 0.207 -48 0.536 -0.0112
173 -0.329

## 2.4.5 PARALLEL LINES

Two straight lines are parallel if they have the same slope.

## Calculating for the intercept of a linear graph (b):

(a) Not knowing the value of m; The graph may be extrapolated, or calcu-
lations performed, at the situation where t = 0 . In this case b = ln C p0 .

## (b) Knowing the value of m;

• There are two ways: for any point on the graph: y 1 = mx 1 + b and b = y 1 – mx 1
Hence, b may be calculated from a knowledge of y 1 and x 1 .

• Secondly, the graph may be extrapolated or calculations performed, at the situation where
t = 0 . In this case, b = ln C p

## Basic Pharmacokinetics REV. 00.1.6 2-30

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.4.6 GRAPHICAL EXTRAPOLATIONS

How far can I predict? It is dangerous to extrapolate on non-linear graphs, and it is unwise to extrapolate
too far on linear graphs. Most often extrapolation is used to find the value of y at a
selected value of x.

If the size of the graph does not permit physical extrapolation to the desired value,
the required result may be obtained by calculation. The values of m and b must be
found as shown above. Then: y' = mx' + b , where x' is the selected value of x,
and y' is the new calculated value for y.

## 2.4.7 SIGNIFICANCE OF THE STRAIGHT LINE

The more closely the experimental points fit the best line, and the higher the num-
ber of points, the more significant is the relationship between y and x. As you may
expect, statistical parameters may be calculated to indicate the significance.
What good is a straight By using all the experimental data points, calculations may be made to find the
line? optimum values of the slope m, and the intercept, b. From these values the corre-
lation coefficient (r).and the t-value may be obtained to indicate the significance.
Exact details of the theory are available in any statistical book, and the calculations
may most easily be performed by a computer using The Scientist or PKAnalyst in
this course.

The advantage of computer calculation is that it gives the one and only best fit to
the points, and eliminates subjective fitting of a line to the data.

## 2.4.8 GRAPHICAL HONESTY

How many points are Any graph drawn from 2 points is scientifically invalid. Preferably, straight-line
needed? graphs should have at least 3 - 5 points, and non-linear graphs a few points more.
Can I discard points that As a graph is a visual representation which enables the experimenter to average
don’t fit? out the small deviations in results from the “perfect” result, no one result can be
unjustifiably ignored when the best fitting line is drawn. Still, an “errant” point
may be justifiably ignored if there were unusual experimental circumstances
which may have caused the deviation. Thus it is not justifiable to omit a point
solely because it “does not fit”.

## 2.4.9 AXES WITH UNEQUAL SCALES

In mathematical studies, the scales of the x and y are almost always equal but very
often in plotting chemical relations the two factors are so very different in magni-

## Basic Pharmacokinetics REV. 00.1.6 2-31

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

tude that this can not be done. Consequently, it must be borne in mind that the rela-
tionship between the variables is given by the scales assigned to the abscissa and
ordinate rather than the number of squares counted out from the origin.

## FIGURE 2-5. y = 0.1 x

0.35
0.30
0.25
0.20
0.15
0.10
0.05
0.00
0 2 4 6 8 10

10
8
6
4
2
0
0 2 4 6 8 10

For example (shown in Figure 2-5), these two parabolic curves represent the same
equation the only difference is the scales are different along the y axis.

Frequently it is not convenient to have the origin of the graph coincide with the
lower left hand corner of the coordinate paper. Full utilization of the paper with
suitable intervals is the one criteria for deciding how to plot a curve from the
experimental data. For example, the curve below (Figure 2-6) is poorly planned,
where the following (Figure 2-7) is a better way of representing the gas law
PV = nRT

## Basic Pharmacokinetics REV. 00.1.6 2-32

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

50
40
30
20
10
0
0 4 8 12 16 20

## FIGURE 2-7. Well arranged graph

25
20
15
10
5
0
1 2 3 4 5 6 7 8 9 10

P ( )

## 2.4.10 GRAPHS OF LOGARITHMIC FUNCTIONS

2
Previously variables were raised to constant powers; as y = x . In this section
x
constants are raised to variable powers; as y = 2 . Equations of this kind in which
the exponent is a variable are called (naturally) exponential equations. The most
x
important exponential equation is where e is plotted against x .

## Basic Pharmacokinetics REV. 00.1.6 2-33

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Exponential or logarithmic equations are very common in physical chemical phe-

nomenon. One of the best ways of determining whether or not a given set of phe-
nomenon can be expressed by a logarithmic or exponential equation is to plot the
logarithm of one property against another property. Frequently a straight line is
obtained and its equation can be readily found. For example:

## In the following table the plasma concentration ( C p ) of the immunosuppressant

cyclosporine was measured after a single dose (4mg/kg) as a function of time.

## TABLE 2-12 Plasma concentration of cyclosporine

ng
Concentration ------
Time (hours) ml
0.25 1900
.75 1500
1.5 1300
4 900
6 600
8 390

## D’mello et al., Res. Comm. Chem. Path. Pharm. 1989: 64 (3):441-446

These can be illustrated in three different ways (Figures 2-8, 2-9, 2-10),
• Concentration vs. time directly
• Log concentration vs. time directly
• Log concentration vs. time with concentration plotted directly on to log scale of ordinate.

## FIGURE 2-8. Concentration (ng/ml) vs. time (hr)

2000
1800
1600
1400
1200
1000
800
600
400
200
0 1 2 3 4 5 6 7 8

## Basic Pharmacokinetics REV. 00.1.6 2-34

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## FIGURE 2-9. Log Concentration vs. time

3.200
Log Concentration - Time Curve
3.100
3.000
2.900
2.800
2.700
2.600
2.500
2.400
2.300
0 1 2 3 4 5 6 7 8

## FIGURE 2-10. Log concentration (on log scale) vs. time

10000

1000

100
0 1 2 3 4 5 6 7 8

Graphing is much easier because the graph paper itself takes the place of a loga-
rithmic table, as shown in Figure 1-10.

Only the mantissa is designated by the graph paper. Scaling of the ordinate for the
characteristic is necessary. The general equation y = Be ax can be expressed as a
straight line by basic laws of indices.

ax
ln y = ln B + ln ( e ) → ln y = ln B + ax or ln y = ax + ln B

One axis is printed with logarithmic spacing, and the other with arithmetic spac-
ing. It is used when a graph must be plotted as in the example (Figure 1-4)
y = log [ C p ] and x = t .

## Basic Pharmacokinetics REV. 00.1.6 2-35

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## In this example, the vertical logarithmic axis is labelled “Plasma concentration of

cyclosporine” and the values plotted are the ordinary values of [ C p ] . Thus, there is
no need to use logarithmic tables, because the logarithmic spacing is responsible
for obtaining a straight line.

## a) there are not enough cycles to incorporate all the data

b) obtaining the value of the slope is difficult. In this instance the slope is given by:

y2 – y1 ln [ C p ] 2 – ln [ C p ] 1
m = ---------------
- = --------------------------------------------
x2 – x1 t2 – t1

Hence, before calculating the value of m, the two selected values of [ Cp ] 1 and [ Cp ] 2
must be converted, using a calculator, to ln [ Cp ] 1 and ln [ C p ] 2 in order to satisfy the
equation. The same problem may arise in obtaining the intercept value, b.

The two problems may be avoided by plotting the same data on ordinary paper, in
which case the vertical axis is labelled “log plasma concentration”. However, in
this instance the ordinary values of [ C p ] must be converted to ln [ Cp ] prior to plot-
ting. It is the ln [ Cp ] values which are then plotted.

The calculation of the slope is direct in this case, as the values of y 1 and y 2 may be
read from the graph. Hence, one must consider the relative merits of semilogarith-
mic and ordinary paper before deciding which to use when a log plot is called for.

In the case of semilog graphs the slope may be found in a slightly different manner,
i.e., taking any convenient point on the line ( y 1 ) we usually take the as the second
point, ( y 2) one half of ( y 1 ) . Thus,

y1 
ln  ------------------- ln  ----------
- 1
ln y 1 – ln ( ( 1 ⁄ 2 )y 1 )  ( 1 ⁄ 2 )y 1  1⁄2 ln 2 - 0.693
m = ----------------------------------------------
- = ------------------------------
- = --------------------- = ------------- = -------------
t 1 – t2 t 1 – t2 t 1 – t2 t1 – t2 –t1 ⁄ 2

(in which case, t 2 – t 1 is called the half-life t½ ). Since t1 < t2 , then t1 – t2 = –t1 ⁄ 2
0.693 0.693
because m = ------------- = – k
–t1 ⁄ 2
and k = ------------- .
t1 ⁄ 2

## Basic Pharmacokinetics REV. 00.1.6 2-36

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.4.12 LOG - LOG COORDINATES

a
Functions of the type y = Bx give straight lines when plotted with logarithms
along both axis.

## y = mx + b . This is directly applicable to parabolic and hyperbolic equations

previously discussed (see Figure 1-5).

## 2.4.13 PITFALLS OF GRAPHING: POOR TECHNIQUE

The utility of these procedures requires proper graphing techniques. The picture
that we draw can cause formation of conceptualizations and correlations of the
data that are inconsistent with the real world based simply on a bad picture. Conse-
quently the picture must be properly executed.

The most common error is improper axes labelling. On a single axis of rectilinear
coordinate paper (standard graph paper), a similar distance between two points
corresponds to a similar difference between 2 numbers. Thus,

## FIGURE 2-11. Graphing using standard number spacing

40
30
20
10
0
0 5 10 15 20 25 30

## Basic Pharmacokinetics REV. 00.1.6 2-37

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## FIGURE 2-12. Nonstandard (incorrect) graph

40
30
20
10
1

0
0 2 5 10 20 30

Obviously, the distance (Time) on the graph 12 between 0 and 2 hours should not
be the same as the distance between 10 and 20 hours. It is, and therefore Figure 2-
12 is wrong.

Similarly, the use of similar paper may result in some confusion. With logarithms
the mantissa for any string of numbers, differing only by decimal point placement,
is the same. What differentiates one number from another, in this case, is the char-
acteristic. Thus,

## Number Mantissa Characteristic Log

234 .3692 2 2.3692
23.4 .3692 1 1.3692
2.34 .3692 0 0.3692
0.234 .3692 -1 1.3692

## The paper automatically determines the relationship between strings of numbers

(mantissa) by the logarithmic differences between the numbers on the axis within a
cycle. The student must determine the order of magnitude (characteristic) to be rel-
egated to each cycle.

## Basic Pharmacokinetics REV. 00.1.6 2-38

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## FIGURE 2-13. Logarithmic mantissa

Logarithmic Plot
103
234

102
23.4

101

Y axis (units)
2.34

100

0.234

10-1
1.0 1.5 2.0 2.5 3.0 3.5 4.0

X axis (units)

Thus, we see, in Figure 2-13, the cycle on the semilog paper to relate to orders of
magnitude (e.g., 1, 10, 100, 1000, etc.) and consequently the characteristic of the
exponent.

The third common problem is labelling the log axis as log “y”. This is improper. It
is obvious from the spacing on the paper that this function is logarithmic, and thus
the axis is simply labelled “y”.

There are almost as many different errors as there are students and it is impossible
to list them all. These few examples should alert you to possible problems.

0 1 2 3 4 5

## Basic Pharmacokinetics REV. 00.1.6 2-39

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Find the slope by taking any two values on the Y axis such that the smaller value is
one half of the larger. The time that it takes to go from the larger to the smaller is
the half-life. Dividing 0.693 by the half-life yields the rate constant.

## FIGURE 2-15. Curved line which plateaus on semi-log paper.

0 2 4 6 8 10 12

FIGURE 2-16. Curved line which goes up and then straight down on semi-log paper.

0 5 10 15 20 25

Find the terminal slope by taking any two values on the Y axis such that the
smaller value is one half of the larger. The time that it takes to go from the larger to
the smaller is the half-life. Dividing 0.693 by the half-life yields the rate constant.

Plot type one is reasonably easily evaluated. There are 2 important things that can
be obtained: Slope and Intercept. However, the slope and intercept have different
meanings dependent on the data set type plotted. The slope is the summation of all
the ways that the drug is eliminated, -K.

## Basic Pharmacokinetics REV. 00.1.6 2-40

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Data Type Y axis X axis Slope Intercept

IV Bolus Parent Drug Conc. parent compound Time -K dose
C p0 = -----------
Vd
IV Bolus Parent dXu Time -K Kr ⋅ X 0
---------- urine rate of excretion
dt (mid)
parent compound
IV Bolus Parent Xu ∞ – Xu Cumulative urine Time -K kr
--------------
data K ⋅ X0

Plot type two is not usually evaluated in its present form as only the plateau value
can be obtained easily. But again it has different meanings dependent on the data
plotted.

## Data Type Y axis X axis Plateau Value

IV Bolus Parent Xu Cumulative urine Time kr
Xu ∞ = --------------
data parent compound K ⋅ X0

## IV Infusion Drug concentration Time Q Q

Parent parent compound ( C p )ss = ------------ = ----
K⋅V cl

Usually urine data of this type (parent compound - IV bolus) is replotted and eval-
uated as plot 1 (above). Infusion data can be replotted using the same techniques,
but usually is not.

Plot type 3 must be stripped of the second rate constant from the early time points,
thus:

There are 3 things that can be obtained from the plot: the terminal slope (the
smaller rate constant), the slope of the stripped line (the larger rate constant) and
the intercept. The rate constants obtained from a caternary chain (drug moving
from one box to another in sequence in compartmental modeling) are the summa-
tion of all the ways that the drug is eliminated from the previous compartment and
all the ways the drug is eliminated from the compartment under consideration. See
LaPlace Transforms for further discussion.

Again, dependent on the data set type being plotted they will have different values.

## Basic Pharmacokinetics REV. 00.1.6 2-41

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## TABLE 2-16 Plot Type 3 examples

Data
Type Y axis X axis S1 S2 Intercept
IV Bolus Metabolite conc. Time -K small -Klarge km ⋅ X 0
Parent -------------------------------------------------------
( K l arg e – K smal l ) ⋅ V dm

IV Bolus dXmu
--------------- excretion
Time -K small -Klarge k mu ⋅ k m ⋅ X 0
Parent dt (mid) -----------------------------------
-
K l arg e – K smal l
rate of metabolite
into urine
Oral Drug conc. Time -K small -Klarge k a ⋅ fX 0
---------------------------------------------------
-
( K l arg e – K smal l ) ⋅ V d

## Basic Pharmacokinetics REV. 00.1.6 2-42

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.5 Pharmacokinetic MoKdeling

It has been observed that, after the administration of a drug, the concentration of
the drug in the body appear to be able to be described by exponential equations.
Thus, it appears that, even though the processes by which the drug is absorbed. dis-
tributed, metabolized and excreted (ADME) may be very complex, the kinetics
(math) which mimics these processes is made up of relatively simple first order
processes and is called first order pharmacokinetics. A second observation is that
the resulting concentration is proportional to dose. When this is true, the kinetics is
called linear. When this math is applied to the safe and effective therapeutic man-
agement of an individual patient, it is called clinical pharmacokinetics. Thus, in
clinical pharmacokinetics, we monitor plasma concentrations of drugs and suggest
dosage regimens which will keep the concentration of drug within the desired ther-
apeutic range. Pharmacodynamics refers to the relationship between the drug con-
centration at the receptor and the intensity of pharmacological (or toxicological)
response. It is important to realize that we want to control the pharmacological
response. We do that indirectly by controlling the plasma concentration. In order
for this to work, we assume kinetic homogeneity, which is that there is a predict-
able relationship between drug concentration in the plasma (which we can mea-
sure) and drug concentration at the receptor site (which we can not measure). This
assumption is the basis for all clinical therapeutics.

Models are simply mathematical constructs (pictures) which seem to explain the
relationship of concentration with time (equations) when drugs are given to a per-
son (or an animal). These models are useful to predict the time course of drugs in
the body and to allow us to maintain drug concentration in the therapeutic range
(optimize therapy). The simplest model is the one used to explain the observations.
We model to summarize data, to predict what would happen to the patient given a
dosage regimen, to conceptualize what might be happening in disease states and to
compare products. In every case, the observations come first and the explanation
next. Given that a data set fits a model, the model can be used to answer several
different types of questions about the drug and how the patient handles the drug
(its disposition), for example: if the drug were to be given by an oral dose, how
much is absorbed and how fast? Are there things which might affect the absorp-
tion, such as food or excipients in the dosage form itself. What would happen if the
drug were to be given on a multiple dose regimen? What if we increased the dose?
etc.

## Basic Pharmacokinetics REV. 00.1.6 2-43

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## You should be able to:

• be facile in the use of the equations. You should be able to graphically manipulate data sets and
extract pharmacokinetic parameters, applying the appropriate equations or variations of them.
• define all new words used in this section. e g.: Succinctly define, stating rigorously the meaning
of any symbols used and the dimensions of measurement.
• compare and contrast new concepts used in this section. e. g.: rate and rate constant, zero and
first order kinetics, bolus and infusion methods, excretion and elimination, the assumptions
made in pharmacokinetic models with physiological reality. Why can these assumptions be
made?
• pictorially represent any two variables (graph) one vs. the other. e.g. for each of the following
pairs of variables (ordinate against abscissa), draw a graph illustrating the qualitative profile of
their relationship. Where appropriate, indicate the nature of important slopes, intercepts, and
values. Unless you specifically indicate on your plot that semi-log paper is being considered
(write “S-L”), it will be assumed that rectilinear paper is being considered. Graphs are for a
drug given by IV Bolus where applicable.

## The differential equations used result from the

ka model which is our conceptualization of what is
X happening to the drug in the body.

## The box (compartment) is the area of interest. We

want to find out how the mass of drug, X , changes
with time in that compartment, the rate, and how the rates change with time, the
differential equations.
How do we make a dif- The picture that we build is made up of building blocks, consisting of the arrow
ferential equation? and what the arrow touches. The arrow demonstrates how quickly the mass of
drug, X , declines. The arrow times the box that the arrow touches = the rate. Rates
can go in, i.e. arrows pointing to a box mean drug is going in (+ rate). Rates can go
out, i.e. arrows pointing away means drug is going out (- rate). Rate = rate constant
(arrow) times mass of drug (box). So the arrow and box really is a pictorial repre-
sentation of a rate where the rate is the rate constant on the top of the arrow times
what the tail of the arrow touches.

Again, the rate constant, k , tells the magnitude of the rate, k⋅X.

## Basic Pharmacokinetics REV. 00.1.6 2-44

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

k12 k23
X1 X2 X3

The building blocks are k 12 ⋅ X1 and k 23 ⋅ X2 . Every arrow that touches the compart-
ment of interest becomes part of the differential equation. If the arrow goes to the
box, it’s positive; if it goes away from the box, it’s negative.

To find dX1 ⁄ dt (the rate of change of X 1 with time), we simply add up all of the
rates which affect X1 (all of the arrows that touch X1 )

dX 1
--------- = – k 12 ⋅ X 1
dt

and thus:

dX 2
--------- = k 12 ⋅ X 1 – k 23 ⋅ X2
dt

dX 3
--------- = k 23 ⋅ X 2
dt

(Note: the first subscript of the rate constant and the subscript of the box from
which it originates are the same.)

## You should be able to develop the series of interdependent differential equations

which would result from any model. The integration of those equations by use of
the Laplace Table is done by transforming each piece of the equation into the
Laplace domain (looking it up on the table and substituting). The algebra per-
formed solves for the time dependent variable: put everything except the variable
(including the operator, s) on the right side and put the variable on the left. Find the
resulting relationship on the left side of the table. The corresponding equation on
the right side of the table in the integrated form.

You should be able to integrate any differential equation developed from any
model (within reason) that we can conceptualize.
(Note: Each subsequent variable is dependent on the ones that precedes it. In fact,
the solutions to the preceding variables are substituted into the differential to
remove all but one of the time dependent functions - the one that we are currently
attempting to solve.)

## Basic Pharmacokinetics REV. 00.1.6 2-45

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.5.2 ONE COMPARTMENT OPEN MODEL

A simplified picture (mathematical construct) of the way the body handles drug is
one where the body can be conceived to be a rapidly stirred beaker of water (a sin-
gle compartment). We put the drug in and the rate at which the drug goes away is
proportional to how much is present (first order). Thus the assumptions are:
• Body homogeneous (one compartment)
• Distribution instantaneous
• Concentration proportional to dose (linear)
• Rate of elimination proportional to how much is there. (First order)

It is important to note that we know some of these assumptions are not true. It is of
little consequence, as the data acts as if these were true for many drugs. The visual
image which is useful is one of a single box and a single arrow going out of the
box depicting one compartment with linear kinetics. The dose is placed in the box
and is eliminated by first order processes. In many cases, more complicated mod-
els (more boxes) are necessary to mathematically mimic the observed plasma ver-
sus time profile when one or more of these assumptions are not accurate. For
example, the two compartment (or multi-compartment) model results when the
body is assumed to not be homogeneous and distribution is not instantaneous.

## Basic Pharmacokinetics REV. 00.1.6 2-46

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.6 The LaPlace Transform

Why do we need to One of the important facets of biopharmaceutics is a familiarity with the principles
know the LaPlace trans- of pharmacokinetics. This latter discipline describes the study of the dynamic pro-
form? cesses by which the body “handles” or “disposes of” an administered drug. These
processes (absorption, distribution, metabolism, and excretion (ADME) are
dynamic in that they represent the time-dependent changes occurring to the drug.
Thus, in pharmacokinetics the time course of these changes, which overall
describe the fate of the administered drug, is described mathematically. If the
mathematical principles are understood, it is then possible to use pharmacokinetics
in clinical practice, such as the design of rational dosage regimens (T.S. Foster and
D.U.A. Bourne, Amer. J. Hosp. Pharm., 34, 70-75 (1977). Understanding
(Bloom’s level 4) is not simply memorizing (Bloom’s level 1) nor calculating
using a memorized equation (Bloom’s level 3). The authors believe that the proper
conceptualizing of the process and the subsequent derivation of the appropriate
equations will lead to an understanding of the mathematical principles, and thus, a
better, more optimal dosing regimen.

## Since a mathematical description of the time-dependent ADME processes is

required, it becomes necessary to deal with their corresponding rate equations.
Inevitably this will involve calculus (mainly integral calculus). However, the
LaPlace Transform provides a method whereby calculus can be performed with
minimal trauma. If a conscientious effort to learn the method is made and applied,
a potentially serious obstacle (the fear of calculus) to the understanding and appre-
ciation of biopharmaceutics will be removed. Indeed, many students will find they
no longer fear integration and are thus free to comprehend the principles underly-
ing pharmacokinetics, which, after all, is the primary aim. So, the LaPlace Trans-
form is a tool which is of great assistance in pharmacokinetics; its utility and
importance should not be lightly disregarded.
The LaPlace Trans- There is, of course, a theoretical background to the LaPlace Transform. However,
form: What Is It? it can be used without recourse to a complete theoretical discussion, though appro-
priate pharmaceutical use of the method is found in the following references:

## M. Gibaldi and D. Perrier, “Pharmacokinetics”, Marcel Dekker, pp. 267-272

(1975).

Basically, the LaPlace Transform is used to solve (integrate) ordinary, linear differ-
ential equations. In pharmacokinetics such equations are zero and first-order rate
equations in which the independent variable is time. For instance, if a differential
equation describing the rate of change of the mass of drug in the body with time is

## Basic Pharmacokinetics REV. 00.1.6 2-47

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

integrated, the final equation will describe the mass of drug actually in the body at
any time.

## The procedure used is to replace the Independent variable (time) by a function

containing the LaPlace Operator, whose symbol is “s”. In doing so we have
replaced the time domain by a complex domain. This is analogous to replacing a
number by its logarithm. Once in the complex domain, the transformed function
may be manipulated by regular algebraic methods. Then the final expression in the
complex domain is replaced by its equivalent in the time domain, yielding the inte-
grated equation. This ultimate process is analogous to taking an antilogarithm.

## 2.6.1 TABLE OF LAPLACE TRANSFORMS

A table of useful LaPlace The replacement of expressions in one domain by their equivalents in another is
transforms is given in accomplished by reference to tables. One column shows time domain expressions,
Section 2.7. Page 2-56.
stated as f ( t ) , and second column shows the corresponding complex domain
expressions, stated as the LaPlace Transform. Note that “ f ( t ) ” simply means
– at
“some function of time”. For example, when f ( t ) is Be , then the LaPlace
Transform is B ⁄ ( s + a ) , where “B” is a constant and “a” is a rate constant

## For example, when the LaPlace Transform is A⁄s

2
, then f ( t ) is At .

2.6.2 SYMBOLISM

## For simplicity in writing transformed rate expressions (and to distinguish them

from untransformed (time domain) expressions), the following symbolism will be
employed:

“a bar will be placed over the dependent variable which is being transformed”.

Example:

If X is the mass of unchanged drug in the body at any time, then X is the LaPlace
Transform of this mass.

## Basic Pharmacokinetics REV. 00.1.6 2-48

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.6.3 CONVENTIONS USED IN DRAWING PHARMACOKINETIC SCHEMA.

When drugs enter the body, they will encounter many different fates. It is impor-
tant to set up the possible fates of the drug by creating a well thought out flow
chart or scheme in order to follow all the events that are occurring in the body as
described by the pharmacokinetic description of the drug. For example, a drug
may be excreted unchanged or may undergo hepatic metabolism to yield active or
inactive metabolites. All of these components are part of pharmacokinetics, which
by definition, includes ADME (the Absorption, Distribution, Metabolism and
Excretion of drugs), and must be considered. This flow chart becomes the back-
bone or the framework upon which to build the equations which describe the phar-
macokinetics of the drug. The differential equations result as a direct consequence
of the flow chart. Using Laplace transforms, the integration of these differential
equations are simplified and provide the pharmacokineticist to (easily?) keep track
of all of the variables in the equation. If the drug scheme or flow chart is set up
incorrectly, this would have a definite negative impact or the expected equations
(as well as the answers and your grade). Below are two examples of how to con-
struct a flow chart. Note that not all drugs follow the same flow chart and it is
quite possible that you will need only to use a portion of these examples when con-
struction your own.

## In general, schema are relatively consistent in the placement of the compartments

in relationship to one another. You might consider, for example a drug, given by
IV bolus, which is metabolized and both the metabolite and the parent compound
are excreted unchanged as shown below:
Feces Body Urine

Dose

Parent Compound kf ku
Xf X Xu

km
kmf kmu
Metabolite Xmf Xm Xmu

## Basic Pharmacokinetics REV. 00.1.6 2-49

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Using the pharmacokinetic symbolism from chapter one, the compartments are
named and placed: metabolites below (or above the plane of the parent com-
pound): compounds going into the urine, to the right; and compounds going into
the feces, to the left of the compounds in the body. The rate constants connecting
the compartments also follow the symbolism from chapter one. In the above flow
chart, K, the summation of all the ways that X is removed from the body, is ku + kf
+ km while K1, the summation of all the ways that Xm is removed from the body,
is kmu +kmf.

Only those compartments are used which correspond to the drug’s pharmacoki-
netic description, thus when a drug is given by IV bolus and is 100% metabolized
with the metabolite being 100% excreted into the urine the model would look like
this:

Dose

km

kmu
Xm Xmu

Thus in this flow chart, K, the summation of all the ways that X is removed from
the body, is km while K1, the summation of all the ways that Xm is removed from
the body, is kmu.

## Basic Pharmacokinetics REV. 00.1.6 2-50

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Drugs sometimes are metabolized to two (or more) different metabolites. In the
first case, the drug is metabolized by two separate pathways resulting in this flow
chart:

Dose
km1

kf X ku Xu
Xf

km2

## kmf2 kmu2 Xmu2

Xmf2 Xm2

In this flow chart, K, the summation of all the ways that X is removed from the
body, is ku + kf + km1 + km2 while K1, the summation of all the ways that Xm1 is
removed from the body, is kmu1 +kmf1 and K3, the summation of all the ways
that Xm2 is removed from the body, is kmu2 + kmf2.

While in a second case, the drug is metabolized and the metabolite is further
metabolized resulting in this flow chart:
Dose

kf X ku Xu
Xf

km1

kmf1 kmu1
Xmf1 Xm1 Xmu1

km2

Xmf2 Xm2

## Basic Pharmacokinetics REV. 00.1.6 2-51

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

In this flow chart, K, the summation of all the ways that X is removed from the
body, is ku + kf + km1 while K1, the summation of all the ways that Xm1 is
removed from the body, is kmu1 +kmf1+ km2 and K3, the summation of all the
ways that Xm2 is removed from the body is kmf2 + kmu2.

Both of these flow charts result in very different end equations, so it is imperative
that the flow charts accurately reflect the fate of the drug.

## 2.6.4 STEPS FOR INTEGRATION USING THE LAPLACE TRANSFORM

• Draw the model, connect the boxes with the arrows depicting where the drug goes.
• The building blocks of the differential rate equations are the arrows and what the tail touches.
• Write the differential rate equation for the box in question. The box is on the left side of the
equal sign and the building blocks are on the other. If the arrow goes away from the box, the
building block is negative, if it is going towards the box, the building block is positive.
• Take the LaPlace Transform of each side of the differential rate equation, using the table where
necessary.
• Algebraically manipulate the transformed equation until an equation having only one trans-
formed dependent variable on the left-hand side is obtained.
• Convert the transformed expression back to the time domain, using the table where necessary to
yield the Integrated equation.

## Basic Pharmacokinetics REV. 00.1.6 2-52

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Following an intravenous injection of a drug (bolus dose), its excretion may be

represented by the following pharmacokinetic scheme:

(Scheme I)
ku
X Xu

## Where X is the mass of unchanged drug in the body at any time.

X u is the cumulative mass of unchanged drug in the urine up to any time, and k u is
the apparent first-order rate constant for excretion of unchanged drug.

## Consider how the body excretes a drug

a. The building block is the arrow and what it touches. This first box (compart-
ment) of interest is [ X ] . The arrow ( k u) is going out, therefore, the rate is going out
and is negative, thus

dX
------- = –k u X (EQ 2-17)
dt

## Taking the LaPlace Transform of each side of equation 2-17:

sX – X0 = – k u X (EQ 2-18)

Note that because the independent variable (time) did not appear on the right-hand
side of equation 2-17, neither did the LaPlace Operator, s, appear there in equation
2-18. All that was necessary was to transform the dependent variable ( X ) into X .
Hence, the table was only required for transforming the left-hand side of equation
2-18.

## Basic Pharmacokinetics REV. 00.1.6 2-53

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

sX + k u X = X0

X ( s + k u ) = X0

X0
X = ------------- (EQ 2-19)
s + ku

A
LetX0 = A Letk u = a X = ---------------- (EQ 2-20)
(s + a)

Note that X is the only transformed dependent variable and is on the left-hand side
of equation 2-19.

## Converting back to the time domain:

–ku t
X = X0e (EQ 2-21)

A
Note that the right-hand side of equation 2-21 was analogous to ---------------- in the
(s + a)
table, because X0 is a constant (the initial dose administered). The left-hand side
of equation 2-21 could be converted back without the table.

## Basic Pharmacokinetics REV. 00.1.6 2-54

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.6.6 SECOND EXAMPLE INTEGRATION USING THE LAPLACE

TRANSFORM

Look at Scheme I again. Consider how the drug goes from the body into the urine.
The next box of interest is Xu . The arrow is coming in, therefore the rate is com-
ing in and is positive. thus,

dXu
--------- = k u X (EQ 2-22)
dt

## (b) Taking the LaPlace Transform of each side of equation 2-22:

sX u – ( X u ) 0 = k u X (EQ 2-23)

But, at zero time, the cumulative mass of unchanged drug in the urine was zero:
that is ( Xu ) 0 = 0 .

sX u = k u X (EQ 2-24)

## (c) Manipulating the transformed equation:

ku X
Xu = --------
- (EQ 2-25)
s

Note that there are two transformed dependent variables. One of them ( X ) can be
replaced by reference to equation 2-19.

ku X0
Xu = --------------------
- (EQ 2-26)
s(s + ku)

A
Let ( k u X0 ) = A Let ( k u ) = a X = ------------------- (EQ 2-27)
s(s + a)

## (d) Converting back to the time domain:

–k t
kuX0 ⋅ ( 1 – e u )
X u = ----------------------------------------
ku

## Basic Pharmacokinetics REV. 00.1.6 2-55

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

Where k u X 0 and k u are analogous to “A” and “a” respectively in the table. Sim-
plifying,
– kut
Xu = X0 ( 1 – e ) (EQ 2-28)

## 2.6.7 THIRD EXAMPLE INTEGRATION USING THE LAPLACE TRANSFORM

During the intravenous infusion of a drug, its excretion may be represented by the
following pharmacokinetic scheme:
(Scheme II)

Infusion Q ku
X Xu

Where Q is the zero-order infusion rate constant (the drug is entering the body at a
constant rate and the rate of change of the mass of drug in the body is governed by
the drug entering the body by infusion and the drug leaving the body by excretion).
The drug entering the body does so at a constant (zero-order) rate.

dX
------- = Q – k u X (EQ 2-29)
dt

## (b) Taking the LaPlace Transform of each side of equation 2-29:

Q
sX – X 0 = ---- – k u X
s

Note that because Q is a rate, and is therefore a function of the independent vari-
able (time), its transformation yields the LaPlace Operator. In this case, Q was
analogous to “A” in the table. But, at zero time, the mass of unchanged drug in the
body was zero: that is, X0 = 0

Q
sX = ---- – k u X (EQ 2-30)
s

## (c) Manipulating the transformed equation:

Q
X = --------------------- (EQ 2-31)
s ( s + ku )

## Basic Pharmacokinetics REV. 00.1.6 2-56

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

A
Let ( Q = A ) Let ( k u = a ) X = ------------------- (EQ 2-32)
s( s + a)

## (d) Converting back to the time domain:

–k t
Q(1 – e u )
X = ----------------------------- (EQ 2-33)
ku

2.6.8 CONCLUSIONS

The final integrations (Eqs. 24, 24, and 28) are not the ultimate goal of pharmaco-
kinetics. From them come the concepts of:
1. (a) elimination half-life
1. (b) apparent volume of drug distribution
2. (c) plateau drug concentrations

These, and other concepts arising from still other equations, are clinically useful.

## Once the method of LaPlace Transforms is mastered, it becomes easy to derive

equations given only the required pharmacokinetic scheme. Under such circum-
stances, it no longer becomes necessary to remember a multitude of equations,
many of which, though very similar, differ markedly in perhaps one minute detail.
As with any new technique, practice is required for its mastery. In this case, mas-
tery will banish the “calculus blues.”

It is also possible to see certain patterns which begin to emerge from the derivation
of the equations. For example, for a drug given by IV bolus the equation is
monoexponential, with the exponent being K, summation of all the ways that the
drug is removed form the body. A graph of the data (Cp v T on semi-log paper)
results in a straight line the slope of which is K, always. If the drug is entirely
metabolized K = km. If the drug is entirely excreted unchanged into the urine, K =
ku. If the drug is metabolized and excreted unchanged into the urine, K = km +ku.
thus K can have different meanings for different drugs, depending on how the
body removes the drug. Following the drug given by IV bolus a second example
of a pattern would be that of the data of the metabolite of the drug. From the
LaPlace, the equation for the plasma concentration of the metabolite of the drug
has in it K and K1, the summation of all the ways that the metabolite is removed
from the body, always. K1 would have different meanings depending on how the
metabolite is removed from the body.

## Basic Pharmacokinetics REV. 00.1.6 2-57

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

After several years teaching, I was fortunate to have a resident rotate through our
pharmacokinetic site. She had come with a strong Pharmacokinetcs background
and during our initial meeting, she had told me that she had a copy of John Wag-
ner’s new textbook on pharmacokinetcs. She was excited that, finally, there was a
compilation of all the equations used in pharmacokinetics in one place.

“There are over 500 equations in the new book and I know every one,” she said.
“I’m not sure which one goes with which situation, though.” OOPS!

Throughout this text and on each exam, each equation is derived from first princi-
ples using scientific method, modeling and LaPlace Transforms in the hopes that
memorization will be minimized and thought (and consequently proper interpreta-
tion) would be maximized.

## Basic Pharmacokinetics REV. 00.1.6 2-58

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.6.9 TABLE OF LAPLACE TRANSFORMS

A, B are constants

## x is a variable, dependent on time ( t )

m is a power constant

## Time Function, F ( t ) LaPlace Transform, f ( s )

A A
---
s
At A-
---
2
s

At
m A ( m! -)
--------------
m+1
s
– at A-
Ae ----------
s+a
m – at A
At e --------------------------
-
m+1
(s + a)
– at A
A(1 – e ) -------------------
-------------------------- s (s + a )
a
– at A -
At (1 – e )
----- – A
-------------------------- --------------------
2
a a
2 s (s + a)
– at As – B-
– at B( 1 – e ) ------------------
Ae – -------------------------- s (s + a )
a
– at As – B -
A + B
---  ------------------ – Bt
1–e
----- --------------------
 a   a  a
2
s (s + a)

## Basic Pharmacokinetics REV. 00.1.6 2-59

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## Time Function, F ( t ) LaPlace Transform, f ( s )

– bt – at A
A ( e – e )- --------------------------------
-
-------------------------------- (s + a)(s + b)
(a – b)
– bt – at A
A
----------------  1-----------------
– e -  -----------------
1 – e - -----------------------------------
-
(a – b)  b  –
a  s( s + a )( s + b )

 1 – e –bt  1 – e –at A
At- ----------------
A -------------------------------------
-
----- –  ------------------ –  ------------------ 2
s ( s + a) ( s + b)
ab ( a – b )  b2   a2 

1 – at – bt As – B -
---------------- [ ( B + Aa )e – ( B + Ab )e ] --------------------------------
( a – b) (s + a)(s + b)
As – B -
1  ( 1 – e –bt ) ( 1 – e – at )  -----------------------------------
---------------- – bt – at
A ( e – e ) – B  ---------------------- – ----------------------  s( s + a )( s + b )
(a – b)  b a 

  ( 1 – e –bt )  ( 1 – e – at ) As – B
1 B B Bt --------------------------------------
( a – b )  b   ----------------------
---------------- A + --
- ---------------------- – A + --
- – ------ 2
s ( s + a) ( s + b)
b  a  a ab

– ct – bt – at A
e e e -------------------------------------------------
-
A --------------------------------- + --------------------------------- + --------------------------------- (s + a)(s + b)(s + c)
(a – c)(b – c) (a – b )(c – b) (b – a )(c – a)
– ct – bt – at A
(1 – e ) (1 – e ) (1 – e ) ----------------------------------------------------
A ------------------------------------ + ------------------------------------- + ------------------------------------- s( s + a )( s + b )( s + c )
c( a – c )( b – c ) b( a – b)( c – b ) a( b – a )( c – a)
– ct – bt – at A
At- (1 – e ) ( 1 – e ) - --------------------------------------
(1 – e ) - ------------------------------------------------------
-
----- – A -------------------------------------- + -------------------------------------- + 2 2
bc 2 2 s ( s + a) ( s + b ) ( s + c )
c ( a – c) ( b – c ) b ( a – b) ( c – b) a ( b – a )( c – a)
dX
------- sX – X 0
dt
(m + 1 ) A
At -----
------------------- m
(m + 1) s

## Basic Pharmacokinetics REV. 00.1.6 2-60

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## By means of the LaPlace Transform, find the equation for:

1. The amount of drug in the body when the drug is given by IV Bolus (assume no metabolism).
2. The amount of drug in the urine when the drug is given by IV Bolus (assume no metabolism).
3. The amount of metabolite in the body when the drug is given by IV Bolus (assume no parent
drug excretion)
4. The amount of metabolite of the drug in the urine when the drug is given by IV Bolus (assume
no parent drug excretion)
5. The amount of metabolite of the drug in the urine when the drug is given by IV Bolus (assume
both parent drug and metabolite excretion)
6. The amount of drug in the body when the drug is given by IV infusion (assume no metabolism).
7. The amount of drug in the urine when the drug is given by IV infusion (assume no metabolism).
8. The amount of metabolite in the body when the drug is given by IV infusion (assume no parent
drug excretion).
9. The amount of metabolite in the urine when the drug is given by IV infusion (assume no parent
drug excretion).
10. The Rate of excretion of the metabolite into the urine for a drug given by IV bolus when
km+ku=kmu.
11. The amount of the principle metabolite (Xm1) when the drug is eliminated by several pathways
(Xu, Xm1,Xm2,Xm3,etc)
X
12. The concentration of drug, ------ , in the body when the drug is given orally by a delivery system
Vd
which is zero order. What is the concentration at equilibrium ( T ∞ ).
13. The amount of metabolite of a drug in the body when the drug is given by IV Bolus and con-
comitant IV infusion.
14. Disopyramide (D) is a cardiac antiarrythmic drug indicated for the suppression and prevention
of ectopic premature ventricular arrythmias and ventricular tachycardia. It appears that disopy-
ramide is metabolized by a single pathway to mono-dealkylated disopyramide (MND). In a
recent study, the pharmacokinetics of disopyramide were attempted to be elucidated by means
of a radioactive tracer. Since both D and MND would be labeled by the tracer, any equations
showing the time course of the label would show both the D and MND. By means of the
laPlace transform, find the equation for the rate of appearance of tracer into the urine if the drug
were given by IV Bolus.

## Basic Pharmacokinetics REV. 00.1.6 2-61

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2.6.11 LAPLACE TRANSFORM

SOLUTIONS
1. The amount of drug in the body when the drug is given
by IV bolus (assume no metabolism).

Dose

X ku Xu

## X = Xo At time zero, all of the IV bolus is in the com-

partment.
Here K = ku
dX
------- = – k u X
dt

sX – X0 = –kuX

sX + kuX = X o

X ( s + k u )= Xo

Xo
X = -------------
s + ku

A
Let ( X0 ) = A , k u = a ,X = ----------------
(s + a)
– kut
X = Xo e

## Basic Pharmacokinetics REV. 00.1.6 2-62

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 2. the amount of a drug in the urine when the drug is – kut

Xu= Xo ( 1 – e )
given by IV bolus (assume the drug is NOT metabolized

Dose

X ku Xu

## NOTE: You must start where the drug is at time = 0.

Again K = ku

dX
------- = – k u X
dt

sX – X0 = –kuX

sX + kuX = X o

X ( s + k u )= Xo

Xo
X = ------------- You only need to go this far because you
s + ku
need to know X to put it in the equation for Xu. Thus:

dX
--------u- = k u X
dt

## sX u = k u X Substituting from above for X.

X o ku
sX u = -----------------
-
(s + ku)

Xo ku
X u = --------------------
-
s(s + ku)

A
Let ( X0 k u ) = A , k u = a , X u = -------------------
s( s + a )
– kut
ku X o ( 1 – e )
X u = ------------------------------------
-
ku

## Basic Pharmacokinetics REV. 00.1.6 2-63

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 3. the amount of metabolite of a drug in the body km X 0

when the drug is given by IV bolus (assume no parent sX m = -------------- – k mu Xm Substituting for X from above
drug excretion). s + km

km ⋅ Xo
X m = -----------------------------------------
-
( s + k mu ) ( s + k m )
Dose Let ( k m X 0 ) = A , k m = a = K , k mu = b = K1

A
X m = ---------------------------------
X (s + a)(s + b )
( km ⋅ X o ) –k t –k t
- ⋅ ( e mu – e m ) or
X m = ------------------------
km ( k m – k mu )

( km ⋅ Xo )
Xm kmu Xmu - ⋅ ( e – K 1t – e –K t ) in general terms.
X m = ---------------------
( K – K1 )

## Remember: NOTE: We could also:

You must start where the drug is at time = 0. Let ( k m X 0 ) = A , k m = b , k mu = a
Here K = km and K1 = kmu
and then
dx
------ = – k m X
dt ( km ⋅ X o ) –k t –k t
X m = ------------------------- ⋅ ( e m – e mu ) or
( k mu – k m )
sX – Xo = – k m X
( km ⋅ Xo )
sX + k m X = Xo - ⋅ ( e – K t – e –K1t )
X m = ---------------------
( K1 – K )
X ( s + km ) = Xo Both of those equations are identical.

Xo
X = --------------
s + km

A
Let ( X0 ) = A , k m = a , X = ----------------
(s + a)
– kmt
X = Xo e

dX
---------m- = k m X – k mu X m
dt

sX m – Xm0 = k m X – kmu X m

## Basic Pharmacokinetics REV. 00.1.6 2-64

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 4. the amount of metabolite of a drug in the urine X om = 0

when the drug is given by IV bolus (assume the parent
compound is not excreted). sX mu = k mu X m
Here, again, K = km and K1 = kmu
( k mu ) ( k m X o )
sX mu = -----------------------------------------
-
( s + k mu ) ( s + k m )
Dose
( k mu ) ( k m ) ( X o )
X mu = --------------------------------------------
-
s ( s + kmu ) ( s + k m )
X
k mu k m Xo  1 – e –kmt 1 – e –kmut
-  --------------------- – -----------------------
X mu = --------------------
k mu – k m  k m k mu 
km

Xm kmu Xmu

dXm
----------- = k m X – k mu X m
dt

sX m – Xom = k m X – kmu X m

sX m + k mu Xm = k m X

o X
substitute previously solved X = --------------
s + km

km Xo
X m ( s + k mu ) = --------------
s + km

km X o
X m = -----------------------------------------
-
( s + k mu ) ( s + k m )
– kmt – kmut
km Xo ( e –e )
X m = --------------------------------------------------
-
( k mu – k m )

dXmu
------------
- = k mu Xm
dt

sX mu – Xom = k muX m
Remember at time zero,

## Basic Pharmacokinetics REV. 00.1.6 2-65

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 5. the amount of metabolite of a drug excreted in dX mu

the urine when both the parent and metabolite are ------------- = k mu Xm
excreted.
dt

## Here K = km + ku and K1 = kmu sX mu – Xom = k muX m = K1Xm

sX mu = K1X m
Dose
( k mu ) ( kmXo )
sX mu = --------------------------------------
( s + K1 ) ( s + K )
ku Xu
X ( k mu ) ( k m ) ( Xo )
X mu = ----------------------------------------
-
s ( s + K1 ) ( s + K )
km
k mu k m X o 1 – e – Kt 1 – e – K1t
X m u = ----------------------  ------------------- – ---------------------
K1 – K  K K1 
Xm kmu Xmu

dX
------- = – k u X – k m X
dt

sX – Xo = – k u X – k m X

sX + k u X + k m X = X o

X ( s + ku + km ) = Xo

( ku + km ) = K

Xo
X = ------------
s+K
– Kt
X = Xo e

dXm
------------ = k m X – k mu Xm = k m X – K1Xm
dt

sXm – X om = k m X – K1Xm

sX m + K1Xm = k m X

km Xo
X m = --------------------------------------
( s + K1 ) ( s + K )

## Basic Pharmacokinetics REV. 00.1.6 2-66

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 6. The amount of drug in the body from a drug given by

IV infusion (assume no metabolism).

Q X ku Xu

## At time zero, all the drug is still in the IV bag, therefore

there is no drug in the body. X0 = 0
Here K = ku
dX
------- = Q – k u X
dt
Q
sX – X0 = ---- – K u X
s
Q
sX + k u X = ----
s
Q
X = ---------------------
s ( s + ku )

Q –k t
X = ----- ( 1 – e u ) or X = Q
---- ( 1 – e –Kt )
ku K

## Basic Pharmacokinetics REV. 00.1.6 2-67

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 7. the amount of drug in the urine when the drug is

given by infusion (assume the drug is NOT metabolized).

Q X ku Xu

Here K = ku

dX
------- = Q – k u X
dt
Q
sX – Xo = ---- – k u X
s
Q
sX + k u X = ----
s
Q
X ⋅ ( s + k u ) = ----
s
Q
X = -------------------------
s ⋅ (s + ku )

dX
--------u- = k u X
dt

sX u – Xo = k u X

sX u = k u X

ku Q
sX u = ------------------------
-
s ⋅ (s + ku)

ku Q
X u = ---------------------------
2
-
s ⋅ ( s + ku )

k u Qt  1 – e –kut
X u = ----------- – Qk u  -------------------
-
ku  k2  u

– kut – Kt
(1 – e ) (1 – e )
X u = Qt – Q ------------------------- or Xu = Qt – Q -----------------------
ku K

## Basic Pharmacokinetics REV. 00.1.6 2-68

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 8. the amount of metabolite of a drug in the body – bt – at

X m = ----------------  ------------------ –  ------------------
A 1–e 1–e
from a drug given by IV infusion (assume no parent drug
excretion) Here K = km and K1 = kmu (a – b) b a

km Q  1 – e – k m t  1 – e – k mu t
X m = -------------------------  -------------------- –  --------------------- or
( k mu – k m )  k m   k mu 
Q X
k m Q  1 – e –Kt  1 – e –K1t
Xm = ---------------------
- ------------------ – ---------------------
( K1 – K )  K   K1 
km

Xm kmu Xmu

dX
------- = Q – k m X
dt
Q
sX – Xo = ---- – k m X
s
Q
sX + k m X = ----
s
Q
X ( s + k m ) = ----
s
Q
X = ----------------------
s ( s + km )
– kmt
(1 – e )
X = Q --------------------------
km

dX
---------m- = k m X – k mu X m
dt

sX m – Xo = k m X – k mu Xm

sX m = k m X – k mu Xm

km Q
X m = ---------------------------------------------
s ( s + k mu ) ( s + k m )

## Basic Pharmacokinetics REV. 00.1.6 2-69

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 9. the amount of metabolite of a drug in the urine dX mu

from a drug given by IV infusion (assume that the parent ------------- = k mu Xm
compound is not excreted). Here K = km and K1 = kmu
dt

sX mu – Xomu = k mu X m substitute X m

k mu k m Q
Q X mu = ----------------------------------------------
2
-
X s ( s + k m ) ( s + k mu )

k mu k m Qt k mu k m Q  ( 1 – e –kmut ) ( 1 – e – k mt )
km X mu = ---------------------- –  ---------------------  ----------------------------- – -------------------------- or
k m ⋅ k mu  k m – k m u  k
2
k
2

mu m

## Xm kmu Xmu k mu k m Qt k mu k m Q  ( 1 – e –Kt ) ( 1 – e –K1t )

X mu = ---------------------- –  --------------------  ------------------------ – --------------------------
K1 ⋅ K  K1 – K   2 2

K K1

dX
------- = Q – k m X
dt
Q
sX – Xo = ---- – k m X
s
Q
sX + k m X = ----
s
Q
X ( s + k m ) = ----
s
Q
X = ----------------------
s ( s + km )

dX
---------m- = k m X – k mu X m
dt

sX m – Xo = k m X – k mu Xm

sX m + k mu X m = k m X

km Q
X m ( s + k mu ) = ----------------------
s ( s + km )

km Q
X m = ---------------------------------------------
s ( s + k m ) ( s + k mu )

k m Q  1 – e –kmut  1 – e –kmt
X m = --------------------  ----------------------- – ---------------------
k m – k mu  k mu   k m 

## Basic Pharmacokinetics REV. 00.1.6 2-70

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 10. the rate of excretion of the metabolite into the dX m

urine for a drug given by IV bolus when ---------- = ( k m X – k muX m )
dt
k m + k u = k mu
sX m – Xom = ( k m X – K1Xm )
In this case, K = ku +km and K1 = kmu and thus K = K1.
This is not normal but could happen. The problem arises sX m + K1X m = k m X
when we get to the LaPlace that assumes the rate con-
stants are different (i.e. a ≠ b ) because for this special km X o
case a = b . X m ( s + K1 ) = ------------
s+K
km Xo
X m = -------------------------------------- (remember- K1 = K)
( s + K ) ( s + K1 )
Dose
km Xo
X m = ------------------------------------------
( s + K1 ) ( s + K1 )
ku Xu km Xo
X
X m = ----------------------2- (kmX0 = A)
( s + K1 )
km
– K1t
X m = k m Xo te
Xm kmu Xmu dX mu
------------
- = k mu Xm
dt
dX mu
dX
. ------- = – k u X – k m X - = k mu k m Xo te –K1t
------------
dt dt

sX – Xo = – k u X – k m X

sX + k u X + k m X = X o

X ( s + ku + km ) = Xo

Xo
X = -------------------------------
( s + k u + km )

K = ( ku + km )

k mu = K1

Xo
X = ----------------
-
(s + K)
– Kt
X = Xo e

## Basic Pharmacokinetics REV. 00.1.6 2-71

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 11. the principal metabolite ( X m1 ) when the drug is k m1 Xo

cleared by several pathways ( X u, X m 1, X m 2 ) X m1 ( s + K1 ) = ----------------
-
(s + K)
In this case K = km1 + km2 + ku, K1 = kmu1 and K2 = k m1 X o
kmu2 X m1 = --------------------------------------
( s + K1 ) ( s + K )
k m1 Xo – K1t –Kt
-(e
X m1 = ---------------- –e )
K – K1
Xm1 kmu1 Xmu1

Dose
km1

X ku Xu

km2

kmu2 Xmu2
Xm2

dX
------- = – k u X – k m1 X – k m2 X
dt

sX – Xo = – k u X – k m1 X – k m2 X

sX + k u X + k m1 X + km2 X = Xo

## X ( s + k u + k m1 + k m2 ) = Xo Let K = ku + km1 + km2

Xo
X = ----------------
-
(s + K)
K = ( k u + k m1 + k m2 ) and K1 = k mu1

dXm1
------------
- = k m1 X – K1X m1
dt

sX m1 – Xm1o = k m1 X – K1X m1

X m1o = 0

k m1 Xo
sX m1 + K1X m1 = ----------------
-
(s + K)

## Basic Pharmacokinetics REV. 00.1.6 2-72

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 12. the concentration of drug X ⁄ Vd in the body k a Q  ( 1 – e –Kt ) ( 1 – e –kat ) 

( k a – K ) 
when the drug is given orally by a delivery system which - ------------------------ – ------------------------- 
X = -------------------
is zero order. What is the concentration in the body at K ka 
equilibrium ( t ∞ )
 1 – e –Kt ) ( 1 – e –kat ) 
-  (-----------------------
ka Q
Here K = ku C = -------------------------- - – ------------------------- 
( k a – K )Vd  K ka 
Q Xa ka X ku Xu k Q
1- ----
1  
If t= ∞ , then e –kt = 0 , thus C = --------------------------
a
-  --- – -
( k a – K )Vd  K ka 

Q
simplified yields: C = ----------
-
KVd
dX
--------a- = Q – k a X a
dt
Q
sX a – Xao = ---- – k a Xa
s

X a0 = 0

sX a + k a Xa = ( Q ⁄ s )

X a ( s + ka ) = ( Q ⁄ s )

Q
X a = ---------------------
s(s + ka)
– kat
Q( 1 – e )
X a = -----------------------------
ka

dX
------- = k a X a – KX
dt

sX – Xo = k a Xa – KX

Xo= 0

ka Q
sX + KX = ---------------------
s ( s + ka )

ka Q
X ( s + K ) = --------------------
-
s ( s + ka )

ka Q
X = --------------------------------------
-
s ( s + ka ) ( s + K )

## Basic Pharmacokinetics REV. 00.1.6 2-73

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 13 the metabolite of a drug in the body Xm given

k m Q  ( 1 – e –K1t ) ( 1 – e –Kt ) 
( K – K1 ) 
by IV infusion and concomitant IV bolus dose. - -------------------------- – ----------------------- 
X m = ---------------------
K1 K 
Infusion:
Here K = km and K1 = kmu IV Bolus:

dX
------- = – KX
dt
Dose
sX – Xo = – KX

Q sX + KX = X o
X
X ( s + K )= Xo
km
Xo
X = -----------
-
s+K
Xm kmu Xmu
dX m
---------- = k m X – K1X m
dt
dX sX m – Xo = k m X – K1X m
------- = Q – KX
dt
Q sX m + K1X m = k m X
sX – Xo = ---- – KX
s
km X o
X m ( s + K1 ) = ------------
Q s+K
sX + KX = ----
s
km Xo
Q X m = --------------------------------------
X ( s + K ) = ---- ( s + K1 ) ( s + K )
s
km Xo – Kt – K 1t
Q -(e – e
X m = --------------------- )
X = -------------------- ( K1 – K )
s( s + K )
Thus,
dX
---------m- = k m X – K1X m km X o
X m =  ---------------------- ( e – e
dt – Kt – K 1t 
) + …
( K1 – K )
sX m – Xo = k m X – K1Xm
 k m Q  ( 1 – e –Kt ) ( 1 – e –K1t ) 
sX m + K1X m = k m X  -----------------  ----------------------- – -------------------------- 
 K1 – K  K K1 
km Q
X m ( s + K1 ) = -------------------
-
s( s + K )
km Q
X m = ----------------------------------------
-
s ( s + K1 ) ( s + K )

## Basic Pharmacokinetics REV. 00.1.6 2-74

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/
Mathematics Review

## 14. By means of the LaPlace transform, find the km X o

equation for the rate of appearance of the tracer in the X m ( s + K1 ) = -----------
-
urine if the drug were given by IV bolus.
s+K

## Here K = ku + km and K1 = kmu km Xo

X m = --------------------------------------
( s + K ) ( s + K1 )
Dose km Xo
- { e –K1t – e –Kt }
X m = ---------------------
( K – K1 )

ku Xu dX mu k mu k m Xo –K1t – Kt
X -{e
------------- = k mu Xm = --------------------- –e }
dt ( K – K1 )
dX dX mu  k mu k m X o
- = k u ( X o e ) +  ---------------------
- { e – e }
– Kt –K1t – Kt
km --------u- + ------------
dt dt   ( K – K1 ) 

Xm kmu Xmu

dX
------- = – k u X – k m X
dt

sX – Xo = – k u X – k m X

sX + k u X + k m X = X o

X ( s + ku + km ) = Xo

( ku + km ) = K

Xo
X = -----------------
(s + K)
– Kt
X = Xo e

dX
--------u- = k m X = k u ( Xo e –Kt )
dt
dX
---------m- = k m X – K1X m
dt

sX m – Xo = k m X – k1Xm

km Xo
sX m + K1X m = ----------------
-
(s + K)

## Basic Pharmacokinetics REV. 00.1.6 2-75

Copyright © 1996-2000 Michael C. Makoid All Rights Reserved http://pharmacy.creighton.edu/pha443/pdf/